In estrogen receptor-positive (ER+) and triple-negative breast cancer cells, data indicate that p47phox amplifies ROS production to sustain HER2/Neu and EGFR signaling [113]. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.